Analyst Research

Report Title Price
Provider: New Constructs, LLC
$25.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: S&P Capital IQ – STARS Reports
$127.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

HCA Holdings Inc Issues FY 2013 Guidance; EBITDA And EPS Guidance Below Analysts' Estimates


Tuesday, 5 Feb 2013 08:29am EST 

HCA Holdings Inc announced that for fiscal 2013, it expects revenue in the range of $33.50-$34.50 billion, adjusted EBITDA in the range of $6.25-$6.50 billion, adjusted EPS (diluted) in the range of $3.00-$3.30. This guidance range excludes the impact of items, if applicable, that are non-operational in nature including items such as, but not limited to, gains or losses on sales of facilities and businesses, gains or losses on early debt retirement and impairments of long-lived assets. The guidance includes estimated EHR incentive income assumptions in a range of $200-$225 million and EHR expenses in a range of $110-$130 million. According to I/B/E/S Estimates, analysts were expecting the Company to report EBITDA of $6.53 billion and EPS of $3.46 for fiscal 2013. 

Company Quote

65.32
-0.94 -1.42%
1:11pm EDT